A subset of people, probably those with autoimmune issues and hyperinflammatory conditions, will be at risk of long term complications in the form of embolisms (via dysfunctional Tcell immune activation of platelets, heparin-independent [or dependent if heparin is mistakenly administered to control said embolisms] immune thrombotic thrombocytopenia) and organ inflammation (via resident dysfunctional Tcells in the heart, lungs etc causing inflammatory issues and compromising organ function) upon subsequent exposure to either booster vaccines and/or virus. This may or may not be identified as a safety signal given that there is no proactive surveillance of long-term issues in vaccinated vs unvaccinated given that the clinical studies switched most of the placebo group to vaccine. Further, the CDC and FDA and vaccine manufacturers clearly have no desire to unearth/identify potential safety signals as evidenced by the way they ignored VITT/myocarditis signals until the international regulatory agencies like EMA demanded information from the VAERS database